Karis Bio

Developer of cell therapies for cardiovascular diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups24 employees language karisbio.com

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%
Coming soon